glp-1 gip therapies muscle preservation 2025 Weight loss with medicines does not result in a disproportionate loss of mass or function in obese mice and humans: Cell Reports Medicine Optimizing GLP-1 therapies for obesity

Patients deserve access to effective obesity treatmentbut they also deserve transparency about what they are putting in their bodies, said Adjoa Kyerematen, Vice President of Communications and Public Affairs

3, 2025, 1:33 p.m.): A previous version of this story misstated that Costco is selling a four-month supply of weight loss medication for $499

You may be surprised to learn that these damaging molecules actually come from our own body, or better said, the chemical reactions that occur in our bodies

In the rapidly evolving field of bioactive compounds, the peptide stack featuring CJC-1295 and Ipamorelin has become a benchmark for research focused on optimizing physiological function

RxCapital Key Products: HU6, oral Controlled Metabolic Accelerator (mitochondrial uncoupler)

The Food and Drug Administration (FDA) currently approves over 100 peptides